Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cryptococcus neoformans variety gattii.

T C Sorrell1

  • 1Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead Hospital, New South Wales, Australia. tanias@icpmr.wsahs.nsw.gov.au

Medical Mycology
|May 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Key lessons from the COVID-19 public health response in Australia.

The Lancet regional health. Western Pacific·2022
Same author

Pathways to COVID-19 'community protection'.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2020
Same author

Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study.

BMC infectious diseases·2019
Same author

Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).

Scientific reports·2016
Same author

Mucormycosis in Australia: contemporary epidemiology and outcomes.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same journal

The clinical utility of bronchoalveolar lavage galactomannan result stewardship within a tertiary medical system.

Medical mycology·2026
Same journal

Cross-reactivity of Cryptococcal Antigen Lateral Flow Assay with Basidiomycetous Yeasts.

Medical mycology·2026
Same journal

Cryptococcus gattii complex infections in southern Brazil: epidemiology, clinical features, management and outcomes from a 33-year cohort.

Medical mycology·2026
Same journal

HAC1 contributes to stress adaptation and virulence in the emerging fungal pathogen Candida auris.

Medical mycology·2026
Same journal

Multicenter Study Reveals Alarming Terbinafine Resistance in Trichophyton indotineae Isolates from Iran.

Medical mycology·2026
Same journal

Human-to-animal transmission cases of the anthropophilic dermatophyte species Trichophyton tonsurans in France, 2021-2025.

Medical mycology·2026
See all related articles

Cryptococcus neoformans var. gattii is an emerging fungal pathogen distinct from C. neoformans var. neoformans. Its unique virulence factors and clinical presentation warrant further investigation for improved treatment strategies.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Fungal Pathogenesis

Background:

  • Cryptococcus neoformans var. gattii is an emerging primary human pathogen, genetically and biochemically distinct from C. neoformans var. neoformans.
  • It is increasingly recognized as a separate species within the Tremellales, commonly found in decaying wood of eucalyptus trees.
  • The life cycle and environmental role of C. n. var. gattii, including its natural reproduction, remain largely unknown.

Purpose of the Study:

  • To investigate the distinct characteristics of Cryptococcus neoformans var. gattii as an emerging pathogen.
  • To explore its ecological niche and potential role in human infections.
  • To compare its virulence determinants and clinical manifestations with C. neoformans var. neoformans.

Main Methods:

Related Experiment Videos

  • Genetic and biochemical analysis to differentiate C. n. var. gattii from C. n. var. neoformans.
  • Environmental sampling to identify its natural habitat and association with eucalyptus trees.
  • In vitro and in vivo studies to assess virulence factors, including secreted phospholipase B.
  • Clinical case analysis to compare disease presentation and treatment response.

Main Results:

  • C. n. var. gattii exhibits distinct genetic and biochemical profiles, supporting its reclassification as a separate species.
  • It is consistently isolated from decaying wood of specific eucalyptus species, suggesting an endophytic lifestyle.
  • Virulence factors such as the polysaccharide capsule, laccase pathway products, and secreted phospholipase B are present and contribute to pathogenicity.
  • Diseases caused by C. n. var. gattii are characterized by increased cryptococcomas, neurological complications, and slower antifungal treatment response, particularly in immunocompetent individuals.

Conclusions:

  • Cryptococcus neoformans var. gattii represents a distinct fungal species with unique pathogenic potential.
  • Its ecological association with eucalyptus trees and specific virulence factors contribute to its emerging role as a human pathogen.
  • Understanding these differences is crucial for accurate diagnosis, effective treatment, and public health management of cryptococcomycosis.